Page 151 - Read Online

Zhao et al. Developments in auxiliary examination of CJD

33. Steinhoff BJ, Zerr I, Glatting M, Schulz-Schaeffer W, Poser S, Alzheimer’s disease. Neurobiol Aging 2011;32:2322.e5-18.
Kretzschmar HA. Diagnostic value of periodic complexes in 50. Wang LH, Bucelli RC, Patrick E, Rajderkar D, Alvarez Iii E, Lim MM,
Creutzfeldt-Jakob disease. Ann Neurol 2004;56:702-8. Debruin G, Sharma V, Dahiya S, Schmidt RE, Benzinger TS, Ward
34. Steinhoff BJ, Räcker S, Herrendorf G, Poser S, Grosche S, Zerr BA, Ances BM. Role of magnetic resonance imaging, cerebrospinal
I, Kretzschmar H, Weber T. Accuracy and reliability of periodic fluid, and electroencephalogram in diagnosis of sporadic Creutzfeldt-
sharp wave complexes in Creutzfeldt-Jakob disease. Arch Neurol Jakob disease. J Neurol 2013;260:498-506.
1996;53:162-6. 51. Caverzasi E, Mandelli ML, DeArmond SJ, Hess CP, Vitali P, Papinutto
35. Binelli S, Agazzi P, Canafoglia L, Scaioli V, Panzica F, Visani E, Di N, Oehler A, Miller BL, Lobach IV, Bastianello S, Geschwind MD,
Fede G, Giaccone G, Bizzi A, Bugiani O, Avanzini G, Tagliavini F, Henry RG. White matter involvement in sporadic Creutzfeldt-Jakob
Franceschetti S. Myoclonus in Creutzfeldt-Jakob disease: polygraphic disease. Brain 2014;137:3339-54.
and video-electroencephalography assessment of 109 patients. Mov 52. Caverzasi E, Henry RG, Vitali P, Lobach IV, Kornak J, Bastianello S,
Disord 2010;25:2818-27. Dearmond SJ, Miller BL, Rosen HJ, Mandelli ML, Geschwind MD.
36. Jung KY, Seo DW, Na DL, Chung CS, Lee IK, Oh K, Im CH, Jung Application of quantitative DTI metrics in sporadic CJD. Neuroimage
HK. Source localization of periodic sharp wave complexes using Clin 2014;4:426-35.
independent component analysis in sporadic Creutzfeldt-Jakob 53. Sarac H, Hajnsek S, Basić S, Henigsberg N, Rados M, Simić G.
disease. Brain Res 2007;1143:228-37. Magnetic resonance spectroscopy and measurement of tau epitopes
37. Mittal S, Farmer P, Kalina P, Kingsley PB, Halperin J. Correlation of of autopsy proven sporadic Creutzfeldt-Jakob disease in a patient with
diffusion-weighted magnetic resonance imaging with neuropathology non-specific initial EEG, MRI and negative 14-3-3 immunoblot. Coll
in Creutzfeldt-Jakob disease. Arch Neurol 2002;59:128-34. Antropol 2008;32 Suppl 1:199-204.
38. Geschwind MD, Potter CA, Sattavat M, Garcia PA, Rosen HJ, Miller 54. Lim CC, Tan K, Verma KK, Yin H, Venketasubramanian N. Combined
BL, DeArmond SJ. Correlating DWI MRI with pathologic and other diffusion-weighted and spectroscopic MR imaging in Creutzfeldt-
features of Jakob-Creutzfeldt disease. Alzheimer Dis Assoc Disord Jakob disease. Magn Reson Imaging 2004;22:625-9.
2009;23:82-7. 55. Bruhn H, Weber T, Thorwirth V, Frahm J. In-vivo monitoring of
39. Tian HJ, Zhang JT, Lang SY, Wang XQ. MRI sequence findings in neuronal loss in Creutzfeldt-Jakob disease by proton magnetic
sporadic Creutzfeldt-Jakob disease. J Clin Neurosci 2010;17:1378-80. resonance spectroscopy. Lancet 1991;337:1610-1.
40. Shiga Y, Miyazawa K, Sato S, Fukushima R, Shibuya S, Sato Y, Konno 56. Lodi R, Parchi P, Tonon C, Manners D, Capellari S, Strammiello R,
H, Doh-ura K, Mugikura S, Tamura H, Higano S, Takahashi S, Itoyama Rinaldi R, Testa C, Malucelli E, Mostacci B, Rizzo G, Pierangeli G,
Y. Diffusion-weighted MRI abnormalities as an early diagnostic Cortelli P, Montagna P, Barbiroli B. Magnetic resonance diagnostic
marker for Creutzfeldt-Jakob disease. Neurology 2004;63:443-9. markers in clinically sporadic prion disease: a combined brain magnetic
41. Vitali P, Maccagnano E, Caverzasi E, Henry RG, Haman A, Torres- resonance imaging and spectroscopy study. Brain 2009;132:2669-79.
Chae C, Johnson DY, Miller BL, Geschwind MD. Diffusion-weighted 57. Renard D, Vandenberghe R, Collombier L, Kotzki PO, Pouget JP,
MRI hyperintensity patterns differentiate CJD from other rapid Boudousq V. Glucose metabolism in nine patients with probable
dementias. Neurology 2011;76:1711-9. sporadic Creutzfeldt-Jakob disease: FDG-PET study using SPM and
42. Caobelli F, Cobelli M, Pizzocaro C, Pavia M, Magnaldi S, Guerra individual patient analysis. J Neurol 2013;260:3055-64.
UP. The role of neuroimaging in evaluating patients affected by 58. Engler H, Lundberg PO, Ekbom K, Nennesmo I, Nilsson A,
Creutzfeldt-Jakob disease: a systematic review of the literature. J Bergström M, Tsukada H, Hartvig P, Långström B. Multitracer study
Neuroimaging 2015;25:2-13. with positron emission tomography in Creutzfeldt-Jakob disease. Eur
43. Zhang JT, Pu CQ, Lang SY. Neuroimaging and electroencephalogram J Nucl Med 2003;30:85-95.
features of a patient with Creutzfeldt-Jakob disease: a follow-up study. 59. Xing XW, Zhang JT, Zhu F, Ma L, Yin DY, Jia WQ, Huang XS, Pu
Med J Chin PLA 2008;33:6. CQ, Lang SY, Yu SY. Comparison of diffusion-weighted MRI with
44. Gao T, Lyu JH, Zhang JT, Lou X, Zhao W, Xing XW, Yang M, Yao 18F-fluorodeoxyglucose positron emission tomography/CT and
Y, Tan QC, Tian CL, Huang XS, Ma L, Yu SY. Diffusion-weighted electroencephalography in sporadic Creutzfeldt-Jakob disease. J Clin
MRI findings and clinical correlations in sporadic Creutzfeldt-Jakob Neurosci 2012;19:1354-7.
disease. J Neurol 2015;262:1440-6. 60. Zhang JT, Pu CQ, Jia WQ, Wu WP, Huang DH, Tian CL, Huang XS,
45. Meissner B, Kallenberg K, Sanchez-Juan P, Collie D, Summers Yu SY. Consistency study of diffusion-weighted magnetic resonance
DM, Almonti S, Collins SJ, Smith P, Cras P, Jansen GH, Brandel JP, imaging with clinical features and EEG in Creutzfeldt-Jakob disease.
Coulthart MB, Roberts H, Van Everbroeck B, Galanaud D, Mellina Chin J Neuromed 2006;5:2.
V, Will RG, Zerr I. MRI lesion profiles in sporadic Creutzfeldt-Jakob 61. Glatzel M, Abela E, Maissen M, Aguzzi A. Extraneural pathologic
disease. Neurology 2009;72:1994-2001. prion protein in sporadic Creutzfeldt-Jakob disease. N Engl J Med
46. Yamada K, Sakai K, Akazawa K, Yuen S, Nishimura T. MR 2003;349:1812-20.
tractography: a review of its clinical applications. Magn Reson Med 62. Zanusso G, Monaco S, Pocchiari M, Caughey B. Advanced tests for
Sci 2009;8:165-74. early and accurate diagnosis of Creutzfeldt-Jakob disease. Nat Rev
47. Chua TC, Wen W, Chen X, Kochan N, Slavin MJ, Trollor JN, Brodaty Neurol 2016;12:325-33.
H, Sachdev PS. Diffusion tensor imaging of the posterior cingulate 63. Masters CL, Harris JO, Gajdusek DC, Gibbs CJ Jr, Bernoulli C, Asher
is a useful biomarker of mild cognitive impairment. Am J Geriatr DM. Creutzfeldt-Jakob disease: patterns of worldwide occurrence
Psychiatry 2009;17:602-13. and the significance of familial and sporadic clustering. Ann Neurol
48. Kantarci K, Avula R, Senjem ML, Samikoglu AR, Zhang B, Weigand 1979;5:177-88.
SD, Przybelski SA, Edmonson HA, Vemuri P, Knopman DS, Ferman 64. World Health Organization. Global surveillance, diagnosis and
TJ, Boeve BF, Petersen RC, Jack CR Jr. Dementia with Lewy bodies therapy of human transmissible spongiform encephalopathies: report
and Alzheimer disease: neurodegenerative patterns characterized by of a WHO consultation. Geneva, Switzerland, 9-11 February 1998.
DTI. Neurology 2010;74:1814-21. Report No. WHO/EMC/ZDI/98.9. Available from: http://www.who.
49. Sexton CE, Kalu UG, Filippini N, Mackay CE, Ebmeier KP. A meta- int/csr/resources/publications/bse/WHO_EMC_ZDI_98_9/en/. [Last
analysis of diffusion tensor imaging in mild cognitive impairment and accessed on July 17, 2017]
Neuroimmunology and Neuroinflammation ¦ Volume 4 ¦ July 21, 2017 143